AGM/EGMJun 4, 2026, 04:25 PM
Aurinia Pharmaceuticals Inc. Shareholders Elect Board, Approve Auditor and Executive Compensation
AI Summary
Aurinia Pharmaceuticals Inc. held its annual general meeting of shareholders on June 3, 2026. Key outcomes included the election of five directors to serve until the 2027 annual general meeting, the approval of PricewaterhouseCoopers LLP as the independent registered public accounting firm, and the approval of the company's executive compensation through a non-binding advisory vote. Voting results showed strong support for all proposals.
Key Highlights
- Aurinia Pharmaceuticals Inc. shareholders elected Kevin Tang, Jeffrey Bailey, Kathy Goetz, Craig Johnson, and Tina S. Nova to the board of directors.
- The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm was approved.
- Shareholders approved, on a non-binding advisory basis, the company's executive compensation ('say on pay').
- Kevin Tang was elected with 96.59% of votes cast for.
- Tina S. Nova was elected with 86.89% of votes cast for.
- The appointment of the auditor received 89.14% of votes cast for.
- The 'say on pay' resolution passed with 93.10% of votes cast for.
Price Impact
More from AUPH